| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | 3 | — | — |
| Sell | 3 | — | — | 1 | — | — | 1 | 1 | — | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2029 | ‡‡‡‡ |
|
| 2028 | ‡‡‡‡‡ |
|
| 2027 | ‡‡‡‡ |
|
| 2026 | 0.61 |
—
—
—
|
| 2025 | 0.52 |
—
—
—
—
|
| 2024 | 0.48 |
—
—
—
—
|
| 2023 | 0.48 |
—
—
—
—
|
| 2022 | 0.48 |
—
—
—
—
—
|
| 2021 | 0.42 |
—
—
—
—
|
| 2020 | 0.10 |
—
|
| 2024 | 2025 | 2026 | Q'26 | |
|---|---|---|---|---|
| Cash | 188.70 | 293.60 | 198.60 | 293.40 |
| Receivables | 724.40 | 834.80 | 932.60 | 1,031.90 |
| Inventory | 4,945.20 | 4,989.00 | 5,173.90 | 5,192.60 |
| Other | 58.90 | 102.80 | 42.50 | 368.80 |
| 6,287.50 | 6,559.00 | 6,715.70 | 6,886.70 |
| 2024 | 2025 | 2026 | Q'26 | |
|---|---|---|---|---|
| Payables | 4,218.20 | 4,092.70 | 4,021.20 | 4,087.10 |
| ST’ Debt | 285.20 | 57.60 | 534.00 | 746.10 |
| Other | 648.70 | 656.10 | 806.00 | 1,414.40 |
| 7,457.70 | 7,251.00 | 7,824.00 | 8,175.40 |
| 10y | 5y | 3y | |
| Sales | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
| May | Aug | Nov | Feb | Year | |
|---|---|---|---|---|---|
| ’26 | 24,941.60 | — | — | — |
—
|
| ’26 | 24,880.80 | 18,915.80 | 19,123.70 | 20,252.20 |
83,172.50
|
| ’25 | 24,265.40 | 18,551.50 | 18,774.50 | 18,799.50 |
80,390.90
|
| ’24 | 24,050.20 | 18,290.70 | 18,557.30 | 18,339.50 |
79,237.70
|
| ’23 | 23,310.30 | 17,919.40 | 18,154.90 | 18,265.11 |
77,649.70
|
| ’22 | 21,269.40 | 16,505.70 | 16,728.40 | 17,383.50 |
71,887.00
|
| ’21 | 22,751.60 | 15,757.60 | 15,408.90 | 15,772.30 |
69,690.40
|
| May | Aug | Nov | Feb | Year | |
|---|---|---|---|---|---|
| ’26 | 728.90 | — | — | — |
—
|
| ’26 | 754.40 | 527.60 | 367.60 | 717.10 |
2,366.70
|
| ’25 | 960.90 | 413.20 | 548.00 | 758.50 |
2,680.60
|
| ’24 | 838.30 | 509.60 | 382.90 | 928.70 |
2,659.50
|
| ’23 | 991.90 | 660.20 | 419.90 | 781.90 |
2,853.90
|
| ’22 | 1,059.00 | 1,078.70 | 645.10 | 730.60 |
3,513.40
|
| ’21 | 2,091.90 | 628.90 | 275.20 | 906.50 |
3,902.50
|
| May | Aug | Nov | Feb | Year | |
|---|---|---|---|---|---|
| ’26 | 232.60 | — | — | — |
—
|
| ’26 | 248.00 | 166.10 | (92.10) | 314.80 |
636.80
|
| ’25 | 421.70 | 19.90 | 57.90 | 281.30 |
780.80
|
| ’24 | 385.10 | 73.60 | (61.60) | 448.70 |
845.80
|
| ’23 | 449.90 | 235.70 | (81.10) | 95.50 |
700.00
|
| ’22 | 560.80 | 779.00 | 264.40 | 354.60 |
1,958.80
|
| ’21 | 1,696.30 | 342.20 | 18.40 | 377.00 |
2,433.90
|
| May | Aug | Nov | Feb | Year | |
|---|---|---|---|---|---|
| ’26 | 0.17 | — | — | — |
—
|
| ’26 | 0.41 | 0.30 | 0.55 | (0.94) |
0.40
|
| ’25 | 0.41 | 0.25 | 0.69 | 0.29 |
1.64
|
| ’24 | 0.72 | 0.46 | 0.62 | 0.43 |
2.23
|
| ’23 | 0.84 | 0.59 | 0.20 | 0.54 |
2.27
|
| ’22 | 0.78 | 0.52 | 0.74 | 0.79 |
2.70
|
| ’21 | 1.00 | 0.49 | 0.20 | (0.37) |
1.47
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | 20.05 | 19.14 | 17.00 | 16.55 | 10.86 | — | — | — |
Low Price
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | 37.99 | 23.88 | 23.47 | 23.20 | 18.83 | — | — | — |
High Price
|
| — | — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | 290,000 | 290,000 | 200,000 | 195,000 | 280,000 | — | — | — |
Employees
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | 0.25 | 0.27 | 0.40 | 0.41 | 0.30 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 71,887.00 | 77,649.70 | 79,237.70 | 80,390.90 | 83,172.50 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 28.83% | 28.02% | 27.82% | 27.68% | 27.18% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,099.50 | 1,935.50 | 1,589.00 | 1,129.70 | 267.80 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.92% | 2.49% | 2.01% | 1.41% | 0.32% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,619.60 | 1,513.50 | 1,296.00 | 958.60 | 217.40 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2,305.20 | 2,459.80 | 2,444.20 | 2,499.10 | 2,640.90 | — | — | — |
Depreciation
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 153.08 | 146.79 | 137.71 | 138.58 | 152.55 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | 2.73 | 2.29 | 2.25 | 1.65 | 0.40 | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7.48 | 5.39 | 4.62 | 4.62 | 4.34 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | (3.31) | (4.07) | (3.15) | (3.27) | (3.17) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.17 | 1.32 | 1.47 | 1.35 | 1.17 | — | — | — |
Free CF/Sh
|
| ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 6.44 | 3.04 | 4.77 | 5.84 | 3.37 | — | — | — |
Book Value/Sh
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 469.60 | 529.00 | 575.40 | 580.10 | 545.20 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | 10.88 | 10.25 | 9.05 | 12.67 | 55.31 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | 0.20 | 0.15 | 0.15 | 0.15 | 0.12 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.53 | 6.53 | 4.25 | 3.60 | 5.26 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | 0.28 | 0.26 | 0.25 | 0.25 | 0.22 | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.85 | 51.54 | 23.12 | 25.27 | 28.89 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,513.40 | 2,853.90 | 2,659.50 | 2,680.60 | 2,366.70 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (1,554.60) | (2,153.90) | (1,813.70) | (1,899.80) | (1,729.90) | ‡‡‡‡‡ | — | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 1,958.80 | 700.00 | 845.80 | 780.80 | 636.80 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 17.90 | (2,158.40) | (1,170.20) | (692.00) | (1,108.30) | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 7,965.10 | 8,910.10 | 8,068.60 | 7,820.10 | 8,946.60 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5,063.10 | 8,454.30 | 7,879.90 | 7,526.50 | 8,748.00 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 3,024.60 | 1,610.70 | 2,747.50 | 3,385.90 | 1,836.20 | — | — | — |
Sh' Equity
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 4.69% | 4.46% | 4.95% | 3.62% | 0.81% | — | — | — |
ROA
|
| ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | 18.83% | 14.33% | 12.17% | 8.86% | 4.30% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ | ‡‡‡‡‡ | 59.05% | 52.22% | 59.47% | 31.26% | 8.33% | — | — | — |
ROE
|
Albertsons Companies (ACI) has shown resilient revenue growth, climbing at a 4.1% CAGR from $59.7 billion in 2017 to $79.2 billion in 2024, outpacing traditional grocers amid inflation and competition from Walmart and Costco. Efficiency shines through with revenue per employee surging 77% to $412,261 by 2025 after slashing headcount by 35%, while gross margins held steady near 28%—though profitability dipped, with EBT margins contracting to 1.4% and net income down 37% from peaks, tied to higher interest and merger costs.
The stalled Kroger merger, blocked by the FTC, triggered a 55% stock plunge from 2022 highs, compounded by one-sided insider selling totaling millions. Yet valuation looks compelling: trailing P/E at 9.1x, EV/Sales at 0.25x, and consensus targets implying 18% upside to fair value, backed by FCF recovery and projections for EPS growth to $2.20 by 2028. With a fortress balance sheet (net debt/EBITDA ~2.5x) and digital/pharmacy strengths, ACI merits a closer look for value hunters eyeing dips below 10x forward P/E.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.